Parnetti, L. et al. CSF and blood biomarkers for Parkinson’s disease. Lancet Neurol. 18, 573–586 (2019).
Hansson, O. Biomarkers for neurodegenerative diseases. Nat. Med. 27, 954–963 (2021).
Palmqvist, S., Mattsson, N., Hansson, O. & Alzheimer’s Disease Neuroimaging, I. Cerebrospinal fluid analysis detects cerebral amyloid-β accumulation earlier than positron emission tomography. Brain 139, 1226–1236 (2016).
Blennow, K., Hampel, H., Weiner, M. & Zetterberg, H. Cerebrospinal fluid and plasma biomarkers in Alzheimer disease. Nat. Rev. Neurol. 6, 131–144 (2010).
-High-Quality-100x70.jpg "Commentary on Breakthrough COVID-19 Infections from Brett Elicker, MD")